CN111559993A - Preparation method of furan methanol compound - Google Patents

Preparation method of furan methanol compound Download PDF

Info

Publication number
CN111559993A
CN111559993A CN202010486443.1A CN202010486443A CN111559993A CN 111559993 A CN111559993 A CN 111559993A CN 202010486443 A CN202010486443 A CN 202010486443A CN 111559993 A CN111559993 A CN 111559993A
Authority
CN
China
Prior art keywords
formula
compound
cdcl
nmr
ionic liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010486443.1A
Other languages
Chinese (zh)
Inventor
倪春节
王月
顾梦婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yancheng Teachers University
Original Assignee
Yancheng Teachers University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yancheng Teachers University filed Critical Yancheng Teachers University
Priority to CN202010486443.1A priority Critical patent/CN111559993A/en
Publication of CN111559993A publication Critical patent/CN111559993A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0277Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature
    • B01J31/0278Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre
    • B01J31/0285Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre also containing elements or functional groups covered by B01J31/0201 - B01J31/0274
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a preparation method of a furan methanol compound, belonging to the field of organic synthesis. The synthesis method comprises the following steps: the compound shown in the formula (I) is subjected to intramolecular ring-opening cyclization reaction under the catalysis of acidic ionic liquid to obtain the furfuryl alcohol compound. The furancarbinol compound is shown as a formula (II). According to the invention, the acidic ionic liquid is used as the catalyst, and transition metal is not used as the catalyst, so that heavy metal residue cannot exist in the product, and the reaction does not need inert gas protection. The invention provides a new way for synthesizing the furan methanol compound.

Description

Preparation method of furan methanol compound
Technical field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a furan methanol compound.
Two background art
Since 1880, furans are commonly used as structural units by chemists in drug synthesis, and thus drugs have biological activities such as antibacterial, insecticidal, antitumor and anti-inflammatory properties. As the compounds have various pharmacological effects, the compounds gradually become one of the hot spots which are continuously concerned by scientists in recent years, and the scientists modify the structures of the compounds to obtain the compounds with better biological activity. Similarly, the furfuryl alcohol compounds and their derivatives have diversified biological activities and have great research value in the fields of medicines, agricultural chemicals, and the like, and thus have received much attention. Although these furfuryl alcohol compounds and their derivatives play an important role in the study of bioactive molecules, examples of ring-opening synthesis by 3, 3-disubstituted oxetanes are rare. The Vanderwal group has reported several examples of ring opening of 3, 3-disubstituted oxetanes with intramolecular oxygen nucleophiles to achieve the synthesis of polysubstituted furancarbinol compounds (Angew. chem. int. Ed.2017,56: 10525-one 10529.). However, the conversion reaction reported requires the use of a stoichiometric amount of trifluoroacetic acid. Therefore, the development of a simple and practical catalytic system for synthesizing the compounds is of great significance.
Disclosure of the invention
The invention aims to provide a preparation method of a furan methanol compound.
The invention provides a furan methanol compound shown in a formula (II),
Figure BDA0002519396890000011
in the formula, R is alkyl, phenyl or common substituent groups in organic compounds such as substituted phenyl, heterocyclic aryl, naphthyl and the like; r' is hydrogen, alkyl or phenyl.
The catalyst adopted by the preparation method is one of sulfonate type acidic ionic liquids, specifically shown in formula (IV), and accounts for 5% of the mole percentage of the formula (I).
Figure BDA0002519396890000012
The solvent in the preparation method is any one of toluene, methanol, ethanol, dichloromethane, chloroform, acetone, dichloroethane, benzene, tetrahydrofuran, ethyl acetate, methyl tert-butyl ether and acetonitrile, and specifically is ethanol.
The preparation method of the invention has the reaction time of 1-24 hours and the reaction temperature of-20-100 ℃; the specific reaction time was 6 hours and the reaction temperature was 60 ℃.
The chemical reaction principle on which the invention is based is as follows:
Figure BDA0002519396890000021
the method provided by the invention adopts a ring-opening cyclization mode to carry out reaction, and the byproduct is only water. The prepared compound contains hydroxyl functional groups, and is easy to derive and modify compounds containing furan structures. Compared with the prior art, the invention has the advantages that: (1) the raw materials and the catalyst have wide sources and are convenient to prepare; (2) expensive metal catalysts are not needed, and heavy metal residues cannot exist in the product; (3) no stoichiometrically strong acids need to be used.
Detailed description of the invention
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The following examples further illustrate the invention in order to provide a better understanding of the invention. The examples do not limit the scope of the invention in any way. Modifications and adaptations of the present invention within the scope of the claims may occur to those skilled in the art and are intended to be within the scope and spirit of the present invention.
In the following examples, the compound having different substituents represented by the formula (I) (0.2mmol), the compound represented by the formula (IV) (5 mol%) and ethanol (0.5ml) were added in this order to a reaction tube, and the reaction temperature was raised to 60 ℃ to effect a reaction. The experiment was stopped after six hours of reaction. Cooling the reaction system, removing the organic solvent by rotary evaporation, and finally carrying out column chromatography by using petroleum ether and ethyl acetate as eluent to obtain the specific corresponding compound (II) by separation.
Example 1
Figure BDA0002519396890000022
33.1mg,95%yield,white solid.
1H NMR(400MHz,CDCl3)7.67-7.64(m,2H),7.45(s,1H),7.38(t,J=7.7Hz,2H),7.29-7.25(m,1H),6.70(s,1H),4.60(s,2H),1.63(s,1H).
13C NMR(100MHz,CDCl3)154.79,139.27,130.64,128.66,127.54,127.17,123.79,105.01,56.85.
Example 2
Figure BDA0002519396890000031
34.6mg,90%yield,white foam.
1H NMR(400MHz,CDCl3)7.64-7.58(m,2H),7.43(s,1H),7.10-7.04(m,2H),6.63(s,1H),4.58(s,2H),1.72(s,1H).
13C NMR(100MHz,CDCl3)162.22(J=162.2Hz),153.94,139.21,127.22,127.02(J=3.3Hz),125.56(J=8.1Hz),115.69(J=21.8Hz),104.70(J=11.3Hz),56.76.
Example 3
Figure BDA0002519396890000032
43.8mg,87%yield,white foam.
1H NMR(400MHz,CDCl3)7.53-7.47(m,4H),7.44(s,1H),6.69(s,1H),4.58(s,2H),1.82(s,1H).
13C NMR(100MHz,CDCl3)153.70,139.54,131.80,129.53,127.33,125.27,121.31,105.57,56.72.
Example 4
Figure BDA0002519396890000033
33.1mg,83%yield,white solid.
1H NMR(400MHz,CDCl3)7.73-7.70(m,2H),7.66-7.63(m,2H),7.51(d,J=0.6Hz,1H),6.86(s,1H),4.61(d,J=2.2Hz,2H),1.74(s,1H).
13C NMR(100MHz,CDCl3)152.65,140.79,134.43,132.58,127.77,123.95,118.86,110.47,108.11,56.58.
Example 5
Figure BDA0002519396890000034
35.4mg,94%yield,colorless oil.
1H NMR(400MHz,CDCl3)7.55(d,J=8.2Hz,2H),7.42(s,1H),7.19(d,J=8.0Hz,2H),6.64(s,1H),4.58(s,2H),2.36(s,3H),1.71(s,1H).
13C NMR(100MHz,CDCl3)155.01,138.88,137.40,129.34,127.98,127.09,123.76,104.29,56.85,21.24.
Example 6
Figure BDA0002519396890000041
39.6mg,97%yield,colorless oil.
1H NMR(400MHz,CDCl3)7.60-7.55(m,2H),7.40(s,1H),6.92(dd,J=9.3,2.3Hz,2H),6.56(s,1H),4.57(s,2H),3.83(s,3H),1.74(s,1H).
13C NMR(100MHz,CDCl3)159.13,154.83,138.58,127.10,125.24,123.75,114.11,103.47,56.85,55.28.
Example 7
Figure BDA0002519396890000042
35.0mg,76%yield,white solid.
1H NMR(400MHz,CDCl3)7.59(d,J=8.4Hz,2H),7.43-7.39(m,3H),6.50(s,1H),4.59(s,2H),1.91(s,1H),1.34(s,9H).
13C NMR(100MHz,CDCl3)155.00,150.66,138.98,127.98,127.07,125.58,123.62,104.41,56.89,34.63,31.24.
Example 8
Figure BDA0002519396890000043
42.2mg,90%yield,white solid.
1H NMR(400MHz,CDCl3)7.75(d,J=8.6Hz,1H),7.41(d,J=0.7Hz,1H),6.87(s,1H),6.60-6.54(m,2H),4.61(s,2H),3.93(s,3H),3.86(s,3H),1.71(s,1H).
13C NMR(100MHz,CDCl3)160.08,156.56,151.21,137.68,127.00,126.75,113.16,107.94,104.68,98.64,57.04,55.38,55.36.
Example 9
Figure BDA0002519396890000051
37.2mg,83%yield,white solid.
1H NMR(400MHz,CDCl3)8.13(s,1H),7.86-7.80(m,3H),7.74(dd,J=8.6,1.6Hz,1H),7.51-7.46(m,3H),6.82(s,1H),4.62(s,2H),1.73(s,1H).
13C NMR(100MHz,CDCl3)154.85,139.50,133.45,132.74,128.39,128.16,127.95,127.72,127.35,126.48,125.98,122.23,122.21,105.64,56.84.
Example 10
Figure BDA0002519396890000052
51.3mg,86%yield,white solid.
1H NMR(400MHz,CDCl3)7.62(d,J=1.7Hz,1H),7.47(s,1H),7.13(d,J=1.6Hz,1H),6.61(s,1H),4.61(s,2H),3.03(t,J=7.2Hz,2H),1.98(t,J=7.2Hz,2H),1.80(s,1H),1.37(s,9H),1.29(s,6H).
13C NMR(100MHz,CDCl3)154.93,153.53,150.06,138.66,135.70,126.93,126.30,120.01,118.29,107.25,56.97,43.80,41.34,34.77,31.57,30.30,28.78.
Example 11
Figure BDA0002519396890000053
24.9mg,76%yield,white foam.
1H NMR(400MHz,CDCl3)7.41-7.38(m,2H),6.58(s,1H),6.55(d,J=3.3Hz,1H),6.45(dd,J=3.4,1.8Hz,1H),4.57(s,2H),1.69(s,1H).
13C NMR(100MHz,CDCl3)147.32,146.29,141.91,138.92,126.95,111.33,105.41,105.02,56.70.
Example 12
Figure BDA0002519396890000061
32.1mg,89%yield,light yellow solid.
1H NMR(400MHz,CDCl3)7.38(s,1H),7.26-7.22(m,2H),7.03(dd,J=5.0,3.7Hz,1H),6.55(s,1H),4.57(s,2H),1.69(s,1H).
13C NMR(100MHz,CDCl3)150.27,138.75,133.50,127.61,127.21,124.36,122.81,105.00,56.72.
Example 13
Figure BDA0002519396890000062
35.5mg,78%yield,white solid.
1H NMR(400MHz,CDCl3)7.94(d,J=7.9Hz,1H),7.40(d,J=0.7Hz,1H),7.37-7.29(m,3H),7.25-7.22(m,1H),6.57(s,1H),4.62(s,2H),3.81(s,3H),1.69(s,1H).
13C NMR(100MHz,CDCl3)151.60,137.12,137.04,126.76,125.90,124.71,122.21,120.23,120.19,109.51,107.33,102.95,57.01,32.92.
Example 14
Figure BDA0002519396890000063
24.1mg,86%yield,colorless oil.
1H NMR(400MHz,CDCl3)7.27(s,1H),6.02(s,1H),4.49(s,2H),2.96-2.84(m,1H),1.67(s,1H),1.23(d,J=6.9Hz,6H).
13C NMR(100MHz,CDCl3)162.83,137.91,125.45,102.95,56.88,27.84,21.00.
Example 15
Figure BDA0002519396890000064
25.9mg,94%yield,colorless oil.
1H NMR(400MHz,CDCl3)7.21(s,1H),6.00(s,1H),4.47(s,2H),1.90-1.82(m,1H),1.63(s,1H),0.89-0.83(m,2H),0.77-0.72(m,2H).
13C NMR(100MHz,CDCl3)158.44,137.64,125.84,103.61,56.86,8.77,6.53.
Example 16
Figure BDA0002519396890000071
28.0mg,92%yield,colorless oil.
1H NMR(400MHz,CDCl3)7.23(s,1H),4.48(s,2H),2.58-2.54(m,2H),2.47-2.42(m,2H),1.86-1.79(m,2H),1.77-1.70(m,2H),1.53(s,1H).
13C NMR(100MHz,CDCl3)151.82,137.83,124.50,116.48,55.92,23.16,22.85,22.82,20.53.
Example 17
Figure BDA0002519396890000072
30.0mg,75%yield,white foam.
1H NMR(400MHz,CDCl3)7.45(d,J=7.6Hz,1H),7.38(s,1H),7.25-7.17(m,2H),7.15-7.10(m,1H),4.57(s,2H),2.98(t,J=7.9Hz,2H),2.76(t,J=8.0Hz,2H),1.82(s,1H).
13C NMR(100MHz,CDCl3)150.77,139.56,134.55,127.94,127.90,126.69,126.58,125.06,119.19,118.61,55.84,28.85,19.41.
Example 18
Figure BDA0002519396890000073
29.5mg,73%yield,white foam.
1H NMR(400MHz,CDCl3)7.61(dd,J=8.3,1.0Hz,2H),7.44-7.39(m,3H),7.31-7.26(m,1H),4.60(s,2H),2.72(q,J=7.6Hz,2H),1.44(s,1H),1.28(t,J=7.6Hz,3H).
13C NMR(100MHz,CDCl3)149.55,139.32,131.60,128.56,127.09,126.90,125.53,122.16,55.73,17.30,14.85.
Example 19
Figure BDA0002519396890000081
37.5mg,75%yield,light yellow solid.
1H NMR(400MHz,CDCl3)7.56(s,1H),7.44-7.38(m,7H),7.26-7.21(m,3H),4.48(s,2H),1.61(s,1H).
13C NMR(100MHz,CDCl3)149.60,139.58,133.03,130.83,129.81,128.88,128.30,127.59,127.36,127.19,125.69,121.82,55.57.

Claims (5)

1. A preparation method of a furan methanol compound comprises the following steps: and (3) carrying out intramolecular ring opening cyclization reaction on the compound shown in the formula (I) under the action of an acidic ionic liquid catalyst to obtain the furancarbinol compound. The furancarbinol compound is represented by the formula (II).
Figure FDA0002519396880000011
R in the formula (I) and the formula (II) is alkyl, phenyl or common substituent groups in organic compounds such as substituted phenyl, heterocyclic aryl, naphthyl and the like; r' is hydrogen, alkyl or phenyl.
2. The method of claim 1, wherein: the acidic ionic liquid is prepared by taking hydrogen sulfate as an anion (HSO 4)-) The quaternary ammonium salt type compound of formula (III).
Figure FDA0002519396880000012
3. The production method according to claim 1 or 2, characterized in that: the solvent of the ring-opening cyclization reaction is any one of toluene, methanol, ethanol, dichloromethane, chloroform, acetone, dichloroethane, benzene, tetrahydrofuran, ethyl acetate, methyl tert-butyl ether and acetonitrile.
4. The production method according to claims 1 to 3, characterized in that: the reaction time is 1-24 hours, and the reaction temperature is-20-100 ℃.
5. The production method according to claims 1 to 4, characterized in that: the acidic ionic liquid accounts for 1-20% of the compound shown in the formula (I) in mol percentage.
CN202010486443.1A 2020-06-01 2020-06-01 Preparation method of furan methanol compound Pending CN111559993A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010486443.1A CN111559993A (en) 2020-06-01 2020-06-01 Preparation method of furan methanol compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010486443.1A CN111559993A (en) 2020-06-01 2020-06-01 Preparation method of furan methanol compound

Publications (1)

Publication Number Publication Date
CN111559993A true CN111559993A (en) 2020-08-21

Family

ID=72069967

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010486443.1A Pending CN111559993A (en) 2020-06-01 2020-06-01 Preparation method of furan methanol compound

Country Status (1)

Country Link
CN (1) CN111559993A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114853699A (en) * 2022-03-25 2022-08-05 盐城师范学院 Synthetic method of benfuriol

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WHITE, ALEXANDER R.等: "A Direct Synthesis of Highly Substituted π-Rich Aromatic Heterocycles from Oxetanes", 《ANGEWANDTE CHEMIE, INTERNATIONAL EDITION》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114853699A (en) * 2022-03-25 2022-08-05 盐城师范学院 Synthetic method of benfuriol

Similar Documents

Publication Publication Date Title
CN114751872B (en) Column [5] arene N-heterocyclic carbene catalyst and preparation method and application thereof
CN111362895A (en) Synthesis method of naphthofuran derivative, naphthofuran derivative and application
CN112209905A (en) Polysubstituted alpha-alkenyl lactone compound, preparation method and application thereof
CN108863890B (en) 4-pyrroline-2-ketone derivative and preparation method thereof
CN111559993A (en) Preparation method of furan methanol compound
CN111592507A (en) Novel green and simple method for preparing polysubstituted furan
CN115093369B (en) Synthesis method of 3, 4-dihydro-isoquinoline-1-ketone compound
CN113045530B (en) Method for preparing naphthopyran compounds by ruthenium catalysis
CN113717103B (en) Preparation method of ketone compound
CN113979982A (en) Preparation method and application of chiral dihydrochromone-2-carboxylic acid compound and derivative thereof
CN109384753B (en) Synthetic method of 2-phenyl-3-methylbenzofuran compound
CN111303096B (en) Synthesis method of polysubstituted 1, 3-dihydronaphtho [2,3-c ] furan derivative
CN107188909B (en) Method for synthesizing indole-substituted or ferrocene-substituted azaarene
EP1803701A1 (en) Process for the preparation of vinyl ether compounds
CN106957251B (en) A method of preparing alkyl thiomethyl ester type compound
CN111440198A (en) 1,10 a-dihydro-2H-pyridine [1,2-d ] [1,4] sulfur nitrogen compound and preparation method thereof
CN113336670B (en) Axial chiral fluorenamine-phenol derivative and preparation method thereof
CN104151274A (en) Synthetic method for gamma-crotonolactone and derivative thereof
CN114920684B (en) Selenium-containing benzamide compound and synthetic method and application thereof
CN115093413B (en) Dihydropyridino spiro [3,4' ] indole and tetrahydropyridofuran [2,3-b ] indol-5-one skeletons and preparation thereof
CN103073498A (en) Novel preparation method for (R)-Alpha-amino-e-caprolactam
CN112125843B (en) Preparation method of 3-hydroxymethyl-4-phenyl-3, 4-dihydroquinolinone compound
CN113234083B (en) Tetrahydroquinoline pyran compound and preparation method and application thereof
CN114805172B (en) Method for synthesizing asymmetric heterocyclic diaryl methane compound
CN113461700B (en) Application of oxygen-promoted dearomatization reaction in construction of spiro-dienone skeleton

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200821